Showing results (81-90 of 218) with videos related to
Sort By:
Pageof 22
Molecular Therapy. Methods & Clinical Development|July 29, 2014
Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectorsNathan VanderVeen, Christopher Paran, Ashley Appelhans, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene TherapyNeha Kamran, Padma Kadiyala, Meghna Saxena, et al.Expert Opinion on Biological Therapy|April 30, 2014
Adenoviral vector-mediated gene therapy for gliomas: coming of ageMaria G Castro, Marianela Candolfi, Thomas J Wilson, et al.Plos One|September 8, 2011
Identification and visualization of CD8+ T cell mediated IFN-γ signaling in target cells during an antiviral immune response in the brainMariana Puntel, Robert Barrett, Nicholas S R Sanderson, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brainJames F Curtin, Gwendalyn D King, Carlos Barcia, et al.Proceedings of the National Academy of Sciences of the United States of America|May 2, 2012
Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cellsNicholas Stephen Rennie Sanderson, Mariana Puntel, Kurt M Kroeger, et al.Neuro-Oncology|February 21, 2020
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental diseaseFlor M Mendez, Felipe J Núñez, Maria B Garcia-Fabiani, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2012
Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cellsJeffrey M Zirger, Mariana Puntel, Josee Bergeron, et al.Oncoimmunology|July 12, 2021
A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1Diana Shah, Andrea Comba, Syed M Faisal, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progressionSumia Ali, James F Curtin, Jeffrey M Zirger, et al.Pageof 22